# Effects of Dipeptidyl Peptidase-4 (DPP-4) Inhibition on Hormonal Responses to Macronutrient Ingestion

> **NCT00885638** · PHASE4 · COMPLETED · sponsor: **Lund University** · enrollment: 12 (actual)

## Conditions studied

- Healthy
- Type 2 Diabetes

## Interventions

- **DRUG:** Sitagliptin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00885638
- **Lead sponsor:** Lund University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2011-05
- **Final completion:** 2012-09
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2014-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00885638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00885638, "Effects of Dipeptidyl Peptidase-4 (DPP-4) Inhibition on Hormonal Responses to Macronutrient Ingestion". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00885638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*